Thermo Fisher Scientific | TMO - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 11.22B 655M 2026-03
Agilent USD 1.48B 20M 2026-06
Becton, Dickinson and Co. USD 2.36B 159M 2026-06
Bio Techne USD 214.56M 29.95M 2026-03
Bio-Rad Laboratories USD 441.8M 15.6M 2026-06
Boston Scientific USD 3.03B 101M 2026-03
Bruker USD 545.9M 3.2M 2026-06
Charles River Laboratories USD 711.76M 11.5M 2026-06
Danaher USD 4.96B 205M 2026-06
Dentsply International USD 620M 2M 2026-06
Edwards Lifesciences USD 973M 60.9M 2026-03
General Electric Aerospace USD 22.36B 186M 2026-06
Henry Schein USD 1.76B 44M 2026-06
Illumina USD 764M 26M 2026-06
Intuitive Surgical USD 1.67B 77.6M 2026-06
IQVIA Holdings USD 3.39B 12M 2026-06
Laboratory Of America USD 2.5B 54.3M 2026-06
Medtronic USD 6.64B 284M 2026-03
Mettler Toledo International USD 731.48M 23.27M 2026-06
Myriad Genetics USD 115.3M 2.7M 2025-12
Olympus JPY 301.38B 32.93B 2026-06
OraSure Technologies USD 22.2M 2.1M 2025-12
Quest Diagnostics USD 1.67B 79M 2026-06
Repligen USD 157.71M 6.16M 2026-06
Revvity USD 709.18M 17.79M 2026-06
Stryker USD 3.74B 172M 2026-06
Thermo Fisher Scientific USD 9.45B 247M 2026-06
Veracyte USD 54.18M 4.06M 2026-06
Waters USD 1.99B 228M 2026-06
Zimmer Biomet Holdings USD 1.77B 40.9M 2026-06